 |
|
rexinoid NRX194204
An orally bioavailable synthetic retinoid X receptor (RXR) agonist with potential antineoplastic and anti-inflammatory activities. Rexinoid NRX 194204 selectively binds to and activates RXRs. Because RXRs can form heterodimers with several nuclear receptors (NRs), RXR activation by this agent may result in a broad range of gene expression depending on the effector DNA response elements activated. Rexinoid NRX 194204 may inhibit the tumor-necrosis factor (TNF)-mediated release of nitric oxide (NO) and interleukin 6 (IL6) and may inhibit tumor cell proliferation. This agent appears to be less toxic than RAR-selective ligands. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Code names: | | AGN194204
NRX194204 | | |
| Previous: | Revia, Revival, Revlimid, RevM10 gene, REXIN-G | | Next: | Rezulin, RFT5-dgA immunotoxin, rhEndostatin, rhizoxin, ribavirin |
|
|
